Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

REPORTING. "It Remains Produced in France": Now Half American, the Manufacturer of Doliprane Wants to Reassure on the Production of the Medicine

Summary by franceinfo.fr
Since its acquisition by the CD&R investment fund, Opella has been half under the American flag and has opened the doors of its industrial site in Compiègne to the press on Thursday. The aim was to reassure us of the sustainability of Doliprane's production.

1 Articles

franceinfo.frfranceinfo.fr
Lean Left

REPORTING. "It Remains Produced in France": Now Half American, the Manufacturer of Doliprane Wants to Reassure on the Production of the Medicine

Since its acquisition by the CD&R investment fund, Opella has been half under the American flag and has opened the doors of its industrial site in Compiègne to the press on Thursday. The aim was to reassure us of the sustainability of Doliprane's production.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

franceinfo.fr broke the news on Friday, June 20, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

Compiègne icon

Compiègne

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal